Statins in pregnancy ‘may be justified’ for high-risk women with FH
FH guidelines recommend stopping statin therapy three months prior to conception.
Ongoing use of pravastatin during pregnancy may be warranted in high-risk women with familial hypercholesterolaemia, according to WA doctors.
Their case series of 13 pregnant women with the genetic disorder highlighted the substantial loss of statin treatment time during the childbearing period, which led to an increased maternal — and possibly fetal — cholesterol burden.
